Mexico anti-aging therapeutics market is projected to grow from $9 Mn in 2022 to $31 Mn in 2030 with a CAGR of 16.78% for the year 2022-2030. The rising elderly population and increasing awareness about anti-aging treatments are the major factors responsible for the growth of the market. The Mexico anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Novastem, Liventia, and ENDYMED are some of the key competitors in the market.
The Mexico anti-aging therapeutics market size is at around $9 Mn in 2022 and is projected to reach $31 Mn in 2030, exhibiting a CAGR of 16.78% during the forecast period. According to information released by the national statistics office, INEGI, household healthcare spending in Mexico exceeded $55 Mn last year or roughly 60% of all health spending in 2022. The numbers provided by INEGI included unpaid work in the health sector, such as caring for the sick and providing preventative care, which was estimated to be equal to 1.6% of GDP. The country's total healthcare expenditure decreased from 6.5% of GDP in 2022 to 6.2% last year. The share of public healthcare spending in the GDP was only 2.5 %.
The body progressively develops aches and pains, fatigue, age spots, wrinkles, hair loss, mood swings, poor concentration, insomnia, frailty, and decreased sex drive as the body gets older. The majority of these changes occur as the cells in the bodies begin to diminish, leading to improper upkeep of organisms. One of the most effective anti-aging medications lately developed in Mexico, rapamycin also has favorable effects on health in old age. The TOR signaling system, which controls a variety of fundamental cellular functions including energy, nutrition, and stress levels, is suppressed by rapamycin. In essence, rapamycin is used to precisely control the principal driver of cellular metabolism. Currently, many antiaging compounds target the calorie-restriction mimetic, autophagy induction, and putative enhancement of cell regeneration, epigenetic modulation of gene activity such as inhibition of histone deacetylases and DNA methyltransferases, are under development in Mexico.
Market Growth Drivers Analysis
A demographic shift is taking place in Mexico, where the number of individuals over 65 is rising. The demand for anti-aging treatments is rising significantly as a result of this population shift. More individuals are making higher salaries as Mexico's economy expands. This is encouraging people to spend more money on anti-aging goods and services. Mexican consumers are becoming more and more conscious of the advantages of anti-aging treatments. The desire for goods and services that can make people look and feel younger has increased as a result of this.
Market Restraints
In Mexico, only a few anti-aging procedures are covered by insurance. This may make it challenging for some customers to pay for these therapies, which may restrict the Mexico anti-aging therapeutics market expansion. The regulatory framework for anti-aging therapeutics in Mexico can be complicated, which can pose challenges for businesses seeking to launch new goods or services.
Key Players
The Federal Commission for the Protection against Sanitary Risk (COFEPRIS) is the regulatory authority in charge of regulating and monitoring the approval of anti-aging medications in Mexico. . COFEPRIS is in charge of ensuring the efficacy and safety of all medications sold in Mexico. It collaborates closely with the pharmaceutical sector to make sure that all medications adhere to the nation's regulatory standards. Pharmaceutical firms must provide COFEPRIS with thorough information on the safety and effectiveness of their anti-aging medications in order for COFEPRIS to approve the drug in Mexico. After reviewing the information, the agency makes a decision regarding whether to permit the drug's selling in the nation. Healthcare Policies and Regulatory Landscape. In addition to approving new medications, COFEPRIS is in charge of post-marketing monitoring to guarantee that medicines remain secure and efficient after they have been released onto the market. Companies that disregard the nation's drug laws may be subject to enforcement action by the government.
1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country
2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)
3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints
4. Competitive Landscape
4.1 Major Market Share
4.2 Key Company Profile (Check all Companies in the Summary Section)
4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)
5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment
6. Methodology and Scope
By Product (Revenue, USD Billion):
By Treatment (Revenue, USD Billion):
By Target Group (Revenue, USD Billion):
By Type of Aging (Revenue, USD Billion):
By Type of Molecules (Revenue, USD Billion):
By Mechanism of Action (Revenue, USD Billion):
By Ingredient (Revenue, USD Billion):
By Distribution Channel (Revenue, USD Billion):
Insights10 will provide you with the reports within 10 key parameters which are:
Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.
Stage I: Market Data Collection
Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.
Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.
Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:
Stage II: Market Data Analysis and Statistical Model
Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.
Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.
The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.
The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.
Data Triangulation & Validation:
Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.
We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.
Stage III: Interpretation and Presentation
Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)
Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.
Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.
We value your inquiry and offer free customization with every report to fulfil your exact research needs.
This report addresses
Need more?